UC patents that paid off
Here is a look at some of UC’s most lucrative patented inventions and products. Revenues include licensing fees, royalties and stock sales over time.
Hepatitis B vaccine: $436 million
Human growth hormone: $245 million
Treatment of intracranial aneurysms: $152 million
Bovine growth hormone: $148 million
Prostate cancer drug: $111 million
Process for splicing genes: $108 million
Immune activator for treating cancer: $88 million
EGF receptor antibodies: $77 million
Interstitial cystitis therapy: $63 million
Dynamic skin cooling device: $49 million
Chromosome painting: $44 milion
Camarosa strawberry: $41 million
Numbers rounded to the nearest million.
Source: University of California
More to Read
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.